Logo image of NXE

NEXGEN ENERGY LTD (NXE) Stock Fundamental Analysis

NYSE:NXE - CA65340P1062 - Common Stock

6.895 USD
+0.3 (+4.63%)
Last: 8/22/2025, 11:37:09 AM
Fundamental Rating

2

Taking everything into account, NXE scores 2 out of 10 in our fundamental rating. NXE was compared to 209 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of NXE have multiple concerns. NXE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NXE has reported negative net income.
In the past year NXE has reported a negative cash flow from operations.
NXE had negative earnings in 4 of the past 5 years.
In the past 5 years NXE always reported negative operating cash flow.
NXE Yearly Net Income VS EBIT VS OCF VS FCFNXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of NXE (-12.53%) is worse than 87.08% of its industry peers.
The Return On Equity of NXE (-18.89%) is worse than 77.99% of its industry peers.
Industry RankSector Rank
ROA -12.53%
ROE -18.89%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE Yearly ROA, ROE, ROICNXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE Yearly Profit, Operating, Gross MarginsNXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for NXE has been increased compared to 1 year ago.
The number of shares outstanding for NXE has been increased compared to 5 years ago.
NXE has a worse debt/assets ratio than last year.
NXE Yearly Shares OutstandingNXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE Yearly Total Debt VS Total AssetsNXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

NXE has an Altman-Z score of 5.42. This indicates that NXE is financially healthy and has little risk of bankruptcy at the moment.
NXE's Altman-Z score of 5.42 is amongst the best of the industry. NXE outperforms 90.91% of its industry peers.
NXE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, NXE belongs to the top of the industry, outperforming 83.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 5.42
ROIC/WACCN/A
WACCN/A
NXE Yearly LT Debt VS Equity VS FCFNXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

NXE has a Current Ratio of 0.75. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.75, NXE is doing worse than 72.25% of the companies in the same industry.
NXE has a Quick Ratio of 0.75. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NXE (0.75) is worse than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
NXE Yearly Current Assets VS Current LiabilitesNXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

NXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.52%, which is quite good.
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NXE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.32% yearly.
NXE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 69.22% yearly.
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y-3.32%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y69.22%

3.3 Evolution

NXE Yearly Revenue VS EstimatesNXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2029 2030 2031 2032 1B 2B 3B
NXE Yearly EPS VS EstimatesNXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NXE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE Price Earnings VS Forward Price EarningsNXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE Per share dataNXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

NXE's earnings are expected to decrease with -2.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.51%
EPS Next 3Y-2.19%

More info and screens

0

5. Dividend

5.1 Amount

NXE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

NYSE:NXE (8/22/2025, 11:37:09 AM)

6.895

+0.3 (+4.63%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners54.47%
Inst Owner Change-4.61%
Ins Owners4.54%
Ins Owner ChangeN/A
Market Cap3.93B
Analysts81.11
Price Target10.21 (48.08%)
Short Float %19.41%
Short Ratio12.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.3%
Min EPS beat(2)-296.04%
Max EPS beat(2)241.44%
EPS beat(4)2
Avg EPS beat(4)-39.73%
Min EPS beat(4)-296.04%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-68.3%
EPS beat(12)4
Avg EPS beat(12)-151.78%
EPS beat(16)4
Avg EPS beat(16)-158.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.86%
PT rev (3m)3.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.2%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.32
P/tB 5.32
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS1.3
TBVpS1.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.53%
ROE -18.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5507.06%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 5.42
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y-3.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y69.22%
EBIT growth 1Y47.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.72%
EBIT Next 3Y3.55%
EBIT Next 5Y1.47%
FCF growth 1Y-28.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.24%
OCF growth 3YN/A
OCF growth 5YN/A